一区二区三区中文av-国产中文字幕三级在线-蜜臂色婷婷热久久精品亚洲一区-国产精品不卡av在线播放

Stock(600222)Hot line:010-61006450

MAH

Leader of "0" Cost MAH 3.0 Era

Platform Overview

Platform Overview
————???????—???????—???????—???????—???????—???????—

 
The project Initiation service platform has more than 20 professional knowledge personnel, all from Shenyang Pharmaceutical University, Chinese Academy of Medical Sciences, Peking Union Medical College and other well-known universities at home and abroad, and has set up generic drug project strategy center, clinical & pharmacology center, intellectual property center, big data analysis center, international new product strategy center, based on the all-round analysis of the pharmaceutical industry and combined with the company's own differentiated positioning, can provide customers with personalized information technology services and comprehensive information assurance.

 Service Content

—???????—???????—???????—???????—???????—???????—???????—???????—???????—

1) Generic Drug Project Initiation: Project development risk assessment is carried out through comprehensive analysis of listed product information, including review overview, patents, market prospects, competition pattern, technical barriers, policy dynamics and other mainstream regulatory countries in Europe, the United States, Japan, China, Canada, Australia and other mainstream regulatory countries.
???????

2)Improvement and Innovation Projects: According to the domestic clinical needs and the guidance of policies and regulations, look for potential improvement and innovation projects, conduct comprehensive research from the aspects of product clinical positioning, market value, competition dynamics, patent layout, and development and listing paths of such projects at home and abroad, determine the adequacy and feasibility of the basis for the topic, and conduct in-depth pharmaceutical technology evaluation, clinical evaluation, development cycle and cost evaluation of the proposed development project.
 

3) Strategy Consulting Service: According to the needs of enterprises, provide partners with product pipeline sustainable development planning, feasibility analysis of new entry fields, and R&D strategy formulation after policy changes, such as the development opportunities and challenges in the cardiovascular field, the key points of improved new drug technology research and development, the analysis of the clinical drug competition pattern of platforms (ophthalmic preparations, enteric-coatedpreparations, sustained-release preparations), and the monthly analysis report of CDE application acceptance products.
 

4)Patent Service: Patent layout of cooperation projects, patent risk assessment of new products, infringement analysis and circumvention strategies, patent search and analysis service, patent tracking and early warning analysis.

5)Resource sharing: The leadingpharm information department cooperates with many well-known pharmaceutical databases at home and abroad (cortellis, intranet, insight, wisdombud), which can provide domestic and foreign listing information, the latest information on industry policies, new products/targets at home and abroad, domestic and foreign product sales and forecast data, market access, clinical guidelines and clinical front-line drug consultation, etc.


 

 

 

 

 

 

 

日本av二区三区在线| 精品人妻一区二区三区观看| 午夜黄色福利在线观看| 久久精品国产亚洲av制服| 成人精品国产一区二区| 亚洲欧美另类重口国产| 国产成人综合欧美日韩另类| 真实国产熟女一区二区三区| 久久99精品综合国产女同| 免费看欧美粗又大爽老| 国产精品毛片视频一区二区| 国产一区免费二区三区四区| 成人av高清在线观看| 熟妇激情欧美在线播放视频| 国产剧情在线观看网站| 人妻中文字幕精品系列| 久久亚洲精品中文字幕一| 国产精品女人毛片在线看| 欧美伊香蕉久久综合网99| 久久99国产综合精品女同| 亚洲av男人的天堂看| 国产三级在线观看视频| 97久久久人妻精品一区 | 国产一区二区麻豆视频| 欧美日韩精品一区二区视频永久免| 亚洲天堂av在线播放| 中文字幕日日夜夜av| 福利在线视频一区二区| 国产91高清免费视频| 亚洲国产精品一区二区av不卡| 男女视频午夜刺激一区二区| 国产真人免费作爱视频网站| 亚洲天堂中文字幕麻豆| 日韩欧美一区二区三区| 免费观看国产裸体视频| 99国产精品久久久久久| 欧美日韩精品免费在线观看| 国产成人免费自拍一区| 欧美三级在线完整版免费| 91日本在线免费观看视频| 国产剧情av在线资源|